Getein Biotech, Inc (SHA:603387)
China · Delayed Price · Currency is CNY 9.91
+0.09 (0.92%)
Sep 28, 2026, 3:00 PM CST
Getein Biotech Market Cap
Getein Biotech has a market cap or net worth of 5.02 billion as of September 28, 2026. Its market cap has increased by 23.70% in one year.
Market Cap
5.02B
Enterprise Value
3.79B
Revenue
1.09B
Ranking
n/a
PE Ratio
16.68
Stock Price
9.91
ChartMarket Cap Chart
Since July 17, 2017, Getein Biotech's market cap has increased from 4.23B to 5.02B, an increase of 18.67%. That is a compound annual growth rate of 1.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 5.02B | 18.23% |
| Dec 31, 2025 | 4.24B | 1.45% |
| Dec 31, 2024 | 4.18B | -25.00% |
| Dec 29, 2023 | 5.58B | -12.00% |
| Dec 30, 2022 | 6.34B | -12.61% |
| Dec 31, 2021 | 7.25B | -18.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sino Medical Sciences Technology | 6.18B |
| Shenzhen YHLO Biotech | 5.88B |
| BMC Medical | 5.72B |
| Shanghai Sanyou Medical | 4.82B |
| Shenzhen Lifotronic Technology | 4.78B |
| Hangzhou AGS MedTech | 4.69B |
| Contec Medical Systems Co.,Ltd | 4.56B |
| Wuhan Huakang Century Clean Technology | 4.45B |